MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

Online pharmacies are no longer allowed to run adverts for weight loss injections, the advertising watchdog has ruled.

A new scientific study into the weight loss drug Mounjaro has found that it may not lead to a worrying side effect as ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

New guidance helps GPs manage patients using privately obtained weight-loss injections, addressing gaps in support like ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical ...